← Evidence map

ArticleOncogene2005

Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo.

Anne Helmrich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

this papercites it

Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo. | OpenQuestion